Form4insider filings, from the source

SEC Form 4 · accession 0002039891-26-000008

Nuvation Bio Inc. · NUVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Philippe Sauvage
Officer — Chief Financial Officer
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 6:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001811063

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF1Jul 15, 2026M39,999$2.17A54,130D
Class A Common StockF1Jul 15, 2026M1$1.97A54,131D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$2.17Jul 15, 2026M39,999D—Oct 6, 2034Class A Common Stock39,999662,333D
Stock Option (Right to Buy)F3$1.97Jul 15, 2026M1D—Feb 27, 2035Class A Common Stock1499,999D

Explanation of responses